IP Library Assignment 067198/0892
Patent Assignment
Reel/Frame 067198/0892

Assignment of Assignor's Interest

Recorded: 2024-04-23 Pages: 10
Assignor
Assignee
ENDO USA, INC.
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
Covered Properties (22)
Implanting Device and Method of Using Same
Patent: 7,214,206 →
Application: 10/406,397 →
Publication: US 2004/0199140
Methods and Compositions for Alleviating Stuttering
Patent: 7,858,638 →
Application: 11/046,706 →
Publication: US 2005/0256029
Compositions and Methods for Treating Precocious Puberty
Patent: 8,062,652 →
Application: 11/155,822 →
Publication: US 2006/0019903
Controlled Release Formulations of Octreotide
Patent: 7,452,868 →
Application: 11/372,749 →
Publication: US 2006/0204540
Method of Inserting an Object Under the Skin
Patent: 7,510,549 →
Application: 11/531,311 →
Publication: US 2007/0073265
Implant Device Release Agents and Methods of Using Same
Patent: 9,120,249 →
Application: 12/109,852 →
Publication: US 2008/0311170
Delivery of Dry Formulations of Octreotide
Patent: 7,759,312 →
Application: 12/171,999 →
Publication: US 2009/0035343
Controlled Release Formulations of Octreotide
Patent: 7,803,773 →
Application: 12/240,690 →
Publication: US 2009/0087470
Combination Treatment for Bladder Cancer
Patent: 8,273,721 →
Application: 12/397,831 →
Publication: US 2009/0227529
Implantation Device for Subcutaneous Implatation of an Object Under the Skin
Patent: 7,850,639 →
Application: 12/415,681 →
Publication: US 2009/0247939
An Implantable Device for the Sustained Release of a Polypeptide
Patent: 8,071,537 →
Application: 12/490,971 →
Publication: US 2010/0021522
Octreotide Implant Having a Release Agent and Uses Thereof
Patent: 7,960,335 →
Application: 12/490,979 →
Publication: US 2010/0022450
Controlled Release Formulations of Octreotide
Patent: 8,507,432 →
Application: 12/814,293 →
Publication: US 2010/0317579
A Method of Manufacturing an Implantable Device
Patent: 8,475,820 →
Application: 12/844,357 →
Publication: US 2010/0292144
Octreotide Implant Having a Release Agent
Patent: 8,383,577 →
Application: 13/098,138 →
Publication: US 2011/0206745
Method of Manufacturing an Implantable Device
Patent: 9,072,786 →
Application: 13/897,895 →
Publication: US 2013/0252894
Implantable Device for the Delivery of Octreotide and Methods of Use Thereof
Application: 17/172,821 →
Publication: US 2021/0161994
Controlled Release Formulations of Octreotide
Application: 18/230,990 →
Delivery of Dry Formulations of Octreotide
Application: 18/237,644 →
Compositions and Methods for Treating Precocious Puberty
Application: 18/419,099 →
Controlled Release Formulations of Octreotide
Application: 18/422,859 →
Delivery of Dry Formulations of Octreotide
Application: 18/428,462 →
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Grant of Security Interest in Patents Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Assignment of Assignor's Interest Feb 16, 2021
From: KUZMA, PETR; QUANDT, HARRY
To: ENDO PHARMACEUTICALS SOLUTIONS, INC.
Reel/Frame 055265/0427 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
Confirmatory Grant of Security Interest in United States Patents Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
Release of Security Interest Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0491 →
Release of Security Interest Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0542 →
Release of Security Interest Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
Assignment of Assignor's Interest Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
Assignment of Assignor's Interest Jun 21, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067800/0107 →
Security Interest Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
Security Interest Aug 26, 2024
From: ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068401/0390 →
Security Interest Aug 26, 2024
From: ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068401/0578 →